title: Prospective, controlled, multi-center study on the effect of an amino-acid-based formula in infants with cow's milk allergy/intolerance and atopic dermatitis.
abstract: Cow's milk allergy/intolerance is treated by complete avoidance of cow's milk proteins. Because cow's milk is an important food for infants, its avoidance may lead to an increased risk of growth impairment. Whilst there is evidence for the beneficial effects of extensively hydrolyzed cow's milk formulate (eHF) in infants with cow's milk allergy/intolerance, little is known about the effects of amino-acid-based formulae (AA) in such infants. We therefore performed a prospective, controlled, multi-center trial to study the efficacy of AA in comparison with eHF, on the growth and clinical symptoms of 73 infants (median age 5.7 months) with cow's milk allergy/intolerance and atopic dermatitis. Cow's milk allergy/intolerance was proven in all infants by double-blind, placebo-controlled food-challenge. We observed a significant improvement in the SCORAD index in both groups, from a mean of 24.6, at entry, to a mean of 10.7 (p < 0.0001) after 6 months. In the AA group there was a significant increase in the length standard deviation score (p < 0.04), whilst there was no difference in the eHF group. The weight-for-length values were stable in both groups. The energy intake during the study was similar in both groups. Both an AA and eHF resulted in a significant clinical improvement in infants with an early onset of symptoms of cow's milk allergy/intolerance. Feeding an AA resulted in improved growth compared with feeding eHF, despite similar dietary intakes, and may therefore be considered as a beneficial alternative in infants with severe cow's milk allergy intolerance.
authors.affiliation: Department of Pediatric Pneumology and Immunology, Children's Hospital Charité, Humboldt University, Augustenburger Platz 1, D-13353 Berlin, Germany. bodo.niggemann@charite.de
authors.forename: B
authors.initials: B
authors.lastname: Niggemann
authors.forename: C
authors.initials: C
authors.lastname: Binder
authors.forename: C
authors.initials: C
authors.lastname: Dupont
authors.forename: S
authors.initials: S
authors.lastname: Hadji
authors.forename: T
authors.initials: T
authors.lastname: Arvola
authors.forename: E
authors.initials: E
authors.lastname: Isolauri
mesh_terms: D000818:Animals; D001835:Body Weight; D003876:Dermatitis, Atopic / Q000178:diet therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D007223:Infant; D007225:Infant Food; D008297:Male; D008892:Milk / Q000009:adverse effects; D016269:Milk Hypersensitivity / Q000178:diet therapy* / Q000209:etiology; D011446:Prospective Studies